Investor Overview
Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is a research and development pharmaceutical company that develops enhanced, patented dermatology and healthcare products. Its primary motivation and focus is to license its patented Invisicare formulations to national and international dermatological, medical, cosmetic, skincare and consumer goods manufacturers and distributors. Skinvisible also produces a variety of skincare products for private label clients.
Shareholder's Information:
Shares Outstanding Are: 93, 459,745
Authorized: 200,000,000
Common OK
Outstanding: 93, 459,745
Public Float: 50%
Insider Ownership: 50%
Fiscal Year End: December 31
February 11, 2010
Skinvisible's Safe4Hours Promotion in Walgreens Expands
- Licensee Receives Third Order in 2010
January 28, 2010
Skinvisible Licensee Receives Reorder from Walgreens
- New First Aid Antiseptic Product Made with Invisicare Selling Nationwide
January 13, 2010
Skinvisible Licensee Announces Agreement with Walgreens
- New First Aid Antiseptic Product Made with Invisicare Available in 7,000 Stores
CLICK HERE TO READ ALL NEWS RELEASES
|
Stock Information:
Go To Full SKVI Quote
OTC:SKVI at Google Finance
Press Releases
|
Skinvisible Web
PDF - 445k)